|
|
 |
|
Viewing report
|
|
|
|
Phosphodiesterases: A Drug Target Family with Broad Therapeutic Impact
Drug and Market Development Publishing, Aug 2005, Pages: 188
- ALTANA Pharma AG
- Bayer HealthCare
- Celgene Corp.
- CrystalGenomics, Inc
- deCODE genetics
- elbion AG
- GlaxoSmithKline, plc
- Glenmark Pharmaceuticals Ltd
- ICOS Corp.
- Inflazyme Pharmaceuticals Ltd
- Memory Pharmaceuticals Corp.
- Neuro3d
- Nissan Chemicals Industries Ltd
- Otsuka America Pharmaceutical, Inc
- Pfizer, Inc
- Plexxikon, Inc
- Sequenom, Inc
- Schering-Plough Corp.
- Wyeth
- Vivus, Inc
Customers who bought this item also bought
Phoenix PDE
Competitor Analysis: HDAC Inhibitors
Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications
Competitor Analysis: Elastase Inhibitors
Histone Deacetylase inhibitors
Competitor Analysis: Raf Inhibitors
Competitor Analysis: Protein Kinase C (PKC) Inhibitors
Competitor Analysis: PI3K-AKT-mTOR Inhibitors
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors: Drug Discovery and Development
Triple Progress Analysis: Lymphoma Therapeutics, Protein Kinase Inhibitors & Therapeutic Antibodies
Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology
|
|
|
|
